Diamantis I. Tsilimigras

1 month ago | jamanetwork.com | Diamantis I. Tsilimigras |Timothy M. Pawlik

Molecular Testing and Targeted Therapies in Hepatobiliary Cancers: A Review Podcast (12:47) 0:00 / 0:00 Abstract Importance  Hepatobiliary cancers are heterogeneous and molecularly complex.

1 month ago | jamanetwork.com | Diamantis I. Tsilimigras |Timothy M. Pawlik

Importance  Hepatobiliary cancers are heterogeneous and molecularly complex. Recent advances in next-generation sequencing (NGS) have enhanced the understanding of their molecular landscape and enabled deployment of biomarker-based gene- and immune-targeted therapies. This review examines the role of molecular testing and targeted therapies in these malignant neoplasms. Observations  Patients with hepatobiliary cancers have poor outcomes.

Feb 28, 2024 | cco.amegroups.org | Diamantis I. Tsilimigras |Timothy M. Pawlik

Have a website account?Log In orRegister for exclusive website content. Home / Vol 13, No 1 (February 29, 2024) / Adjuvant hepatic arterial infusion chemotherapy in patients with resected hepatocellular carcinoma with microvascular... PDF 347 views Full Text 4 views Peer Review File 57 views COI Form 52 views

Jan 29, 2024 | mdpi.com | Diamantis I. Tsilimigras |Xu Han |Hua Zhu |Timothy M. Pawlik

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.